Senores Pharmaceuticals Limited (NSE:SENORES)

Market Cap	33.12B
Revenue (ttm)	4.56B
Net Income (ttm)	675.60M
Shares Out	46.05M
EPS (ttm)	17.26
PE Ratio	41.66
Forward PE	29.97
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,145
Average Volume	19,929
Open	706.75
Previous Close	703.35
Day's Range	700.45 - 732.00
52-Week Range	440.00 - 736.80
Beta	n/a
RSI	59.97
Earnings Date	Nov 14, 2025

About Senores Pharmaceuticals

Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. The company offers critical care pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimal...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2017
• Employees: 194
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SENORES

Financial Performance

In 2024, Senores Pharmaceuticals's revenue was 3.98 billion, an increase of 85.65% compared to the previous year's 2.15 billion. Earnings were 585.60 million, an increase of 86.20%.